All updates
All updates
today 32中文产业新闻精选Chinese source评分6969
文献与产业新闻精选评分6868 FDA greenlights Revolution Medicines' pancreatic cancer gamechanger
文献与产业新闻精选评分7272 FDA greenlights Revolution Medicines' pancreatic cancer gamechanger
FDA Press Releases精选评分7474 FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer
文献与产业新闻评分2222 With Trump's nominee pick in, FDA weighs new deputy commissioner posts: report
文献与产业新闻评分4444 FDA greenlights Abbott’s wearable sensor for capturing diabetic ketoacidosis
FDA Press Releases精选评分6565 FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugar
文献与产业新闻评分1515 STAT+: FDA promises new AI guidance, and what happened at Epic’s UGM
文献与产业新闻评分3232 STAT+: Turkish antitrust authorities probe Teva for allegedly gaming the patent system, disparaging rival drugs
文献与产业新闻评分2121 STAT+: Pharmalittle: We’re reading about RFK Jr. vaccine disclosures, a Merck loss over Medicare prices, and more
中文产业新闻精选Chinese source评分7474 GSK 反义寡核苷酸疗法 Hibsago 获日本批准，用于慢性乙型肝炎功能性治愈
中文产业新闻精选Chinese source评分8383 葛兰素史克 bepirovirsen 在日本获批，成全球首款乙肝功能性治愈疗法
中文产业新闻精选Chinese source评分7171 orforglipron 50天获FDA批准，为国家优先审评券下首个新分子实体
中文产业新闻精选Chinese source评分7575 强生FcRn阻断剂IMAAVY获FDA批准上市，用于温抗体型自身免疫性溶血性贫血
中文产业新闻精选Chinese source评分7171 FDA批准Ultragenyx AAV基因疗法Genglycos用于8岁及以上Ia型糖原贮积病患者
中文产业新闻精选Chinese source评分7777 强生IMAAVY（nipocalimab-aahu）获FDA批准用于温抗体型自身免疫性溶血性贫血
中文产业新闻Chinese source评分6464 先声药业曲拉西利获NMPA批准新适应症，覆盖复发广泛期小细胞肺癌
中文产业新闻Chinese source评分6161 阿斯利康依赛弗酶α注射液中国上市申请获CDE受理，用于2岁及以上低磷酸酯酶症
中文产业新闻精选Chinese source评分7373 强生 nipocalimab 获 FDA 批准用于温抗体型自身免疫性溶血性贫血
文献与产业新闻评分2626 STAT+: Comments on OMB research rule mysteriously removed from federal website
文献与产业新闻评分2727 How Trump’s cuts are reshaping America’s health system
文献与产业新闻精选评分5959 Johnson & Johnson scores 1st FDA label expansion for Imaavy
文献与产业新闻评分3030 Implantica finally nabs FDA approval 8 years after EU green light for reflux implant
文献与产业新闻评分4949 Capricor secures reprieve as FDA extends DMD cell therapy review
文献与产业新闻评分1717 STAT+: Pharmalittle: We’re reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and more
文献与产业新闻评分2121 FDA plans to regulate generative AI
中文产业新闻精选Chinese source评分8080 GSK 贝普若韦生在日本获批，为全球首批功能性治愈慢性乙肝 ASO 药物
中文产业新闻Chinese source评分6464 拜耳sevabertinib在日本获批治疗HER2突变非小细胞肺癌
中文产业新闻精选Chinese source评分8282 GSK乙肝功能性治愈新药bepirovirsen在日本获批，为该药全球首次获批
中文产业新闻精选Chinese source评分8888 葛兰素史克 bepirovirsen 在日本获批用于慢性乙肝功能性治愈
中文产业新闻精选Chinese source评分8080 日本批准GSK反义寡核苷酸疗法bepirovirsen用于慢性乙肝功能性治愈
中文产业新闻精选Chinese source评分7070 武田OX2R激动剂ORZEYFUL在日本获批治疗1型发作性睡病
中文产业新闻Chinese source评分6363 先声药业科赛拉®获NMPA批准新适应症，覆盖复发广泛期小细胞肺癌含拓扑替康方案骨髓保护
中文产业新闻Chinese source评分6363 石药集团EGFR ADC SYS6010拟纳入CDE突破性疗法
中文产业新闻精选Chinese source评分8282 GSK 反义寡核苷酸 Bepirovirsen 在日本获批，为全球首个慢性乙肝功能性治愈新药
中文产业新闻精选Chinese source评分6969 先声药业曲拉西利获NMPA批准新适应症，覆盖广泛期小细胞肺癌全化疗阶段骨髓保护
文献与产业新闻评分5656 Merck, AZ lawsuits against Medicare price negotiations swatted down
文献与产业新闻评分4747 After Trump order, RFK Jr. seeks input on US pediatric vaccine recommendations
文献与产业新闻评分3737 Spruce’s successful FDA talks plant seeds for Q4 filing of ultra-rare disease drug
文献与产业新闻评分5757 STAT+: FDA digital health leader promises generative AI regulatory guidance is coming